More reads
- Biotech IPOs are risky business. Here’s how to do a deal right. (Barron's)
- Bankrupt poop-testing startup uBiome just lost the government approval that's required to run key tests. (Business Insider)
- Pelosi’s drug pricing plan could wipe out some key funding for low-income hospitals. (STAT Plus)
No hay comentarios:
Publicar un comentario